BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8651019)

  • 1. The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry.
    Glade CP; Botermans RJ; van Erp PE; van de Kerkhof PC
    Acta Derm Venereol; 1995 Nov; 75(6):437-41. PubMed ID: 8651019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
    de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
    Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
    van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
    Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.
    Dowd PM; Black AK; Woollard PW; Greaves MW
    Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ultrastructural study of the response of normal skin to epicutaneous application of leukotriene B4.
    van de Kerkhof PC; Peereboom-Stegeman JH; Boeijen J
    J Dermatol; 1991 May; 18(5):271-6. PubMed ID: 1658100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ultrastructural study of transcutaneous migration of polymorphonuclear leukocytes following application of leukotriene B4.
    Paulissen M; Peereboom-Stegeman JH; van de Kerkhof PC
    Skin Pharmacol; 1990; 3(4):236-47. PubMed ID: 1964566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes.
    Kragballe K; Desjarlais L; Voorhees JJ
    Br J Dermatol; 1985 Jul; 113(1):43-52. PubMed ID: 2990516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions.
    Seyger MM; van Pelt JP; van den Born J; Latijnhouwers MA; de Jong EM
    Arch Dermatol Res; 1997 May; 289(6):331-6. PubMed ID: 9209678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides modulate leukotriene B4 mitogenicity toward cultured human keratinocytes.
    Rabier MJ; Farber EM; Wilkinson DI
    J Invest Dermatol; 1993 Feb; 100(2):132-6. PubMed ID: 7679135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
    Wong E; Camp RD; Greaves MW
    J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
    Larkin SW; Fraser L; Showell HJ; Williams TJ; Warren JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):392-8. PubMed ID: 7815355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4.
    Bauer FW; van de Kerkhof PC; Maassen-de Grood RM
    Br J Dermatol; 1986 Apr; 114(4):409-12. PubMed ID: 3008801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids.
    Hébert MJ; Takano T; Holthöfer H; Brady HR
    J Immunol; 1996 Oct; 157(7):3105-15. PubMed ID: 8816421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE.
    Norris PG; Schofield O; Dowd PM; Greaves MW
    Dermatologica; 1987; 174(5):219-23. PubMed ID: 3034690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells.
    Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R
    Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes (PMN) in normal skin and LTB4-stimulated human skin.
    Wozel G; Chang A; Barth J; Happle R; van de Kerkhof PC
    Agents Actions; 1991 Jan; 32(1-2):75-6. PubMed ID: 1647650
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of leukotriene B4--triggered monocyte adhesion.
    Friedrich EB; Tager AM; Liu E; Pettersson A; Owman C; Munn L; Luster AD; Gerszten RE
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1761-7. PubMed ID: 12947016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
    Movat HZ; Rettl C; Burrowes CE; Johnston MG
    Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene B4 induces EMT and vimentin expression in PANC-1 pancreatic cancer cells: Involvement of BLT2 via ERK2 activation.
    Kim YR; Park MK; Kang GJ; Kim HJ; Kim EJ; Byun HJ; Lee MY; Lee CH
    Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():67-76. PubMed ID: 27914516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.